Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12500
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTodoriko, L.D.-
dc.contributor.authorYeremenchuk, I.V.-
dc.contributor.authorShapovalov, V.P.-
dc.contributor.authorIlchyshyn, T.I.-
dc.date.accessioned2017-06-09T11:55:37Z-
dc.date.available2017-06-09T11:55:37Z-
dc.date.issued2014-
dc.identifier.otherУДК 616.24-002.5-097-07-085.28-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12500-
dc.description.abstractAs of October 2012 84 countries had re¬ported at least 1 case of extensively drug resistant tuberculosis (EDR TB). In November 2012, the WHO epidemiological surveillance stated: all new TB cases in the world are 3,7 % of multi-drug resistant tuberculosis (MDR TB); 60,0 % of MDR TB among the new cases of TB are documented in Brazil, China, India, and South Africa.ru_RU
dc.language.isoenru_RU
dc.publisherБуковинський медичний вісникru_RU
dc.subjecttuberculosisru_RU
dc.subjectmulti-drug resistant tuberculosisru_RU
dc.subjectfluoroquinolonesru_RU
dc.subjectmalabsorption syndromeru_RU
dc.subjectтуберкулезru_RU
dc.subjectмультирезистентный туберкулезru_RU
dc.subjectфторхинолоныru_RU
dc.subjectсиндром мальабсорбцииru_RU
dc.subjectтуберкульозru_RU
dc.subjectмультирезистентний туберкульозru_RU
dc.subjectфторхінолониru_RU
dc.subjectсиндром мальабсорбціїru_RU
dc.titleMalabsorption syndrome as a manifestation of systemic effects in advanced forms of pulmonary tuberculosisru_RU
dc.typeArticleru_RU
Appears in Collections:Статті. Кафедра фтизіатрії та пульмонології

Files in This Item:
File Description SizeFormat 
39.pdf305.33 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.